Cargando…
Systematic review and meta-analysis of Coptis chinensis Franch.-containing traditional Chinese medicine as an adjunct therapy to metformin in the treatment of type 2 diabetes mellitus
Background: In China, Coptis chinensis Franch. (Chinese name: Huanglian) prescriptions (HLPs) are prominent hypoglycemic agents used in glycemic control. However, the curative effect of HLPs as adjunctive therapies for type 2 diabetes mellitus (T2DM) has not been evaluated. Based on a systematic rev...
Autores principales: | Pan, Linlin, Zhai, Xin, Duan, Zhanhui, Xu, Kun, Liu, Guirong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492976/ https://www.ncbi.nlm.nih.gov/pubmed/36160405 http://dx.doi.org/10.3389/fphar.2022.956313 |
Ejemplares similares
-
Corrigendum: Systematic review and meta-analysis of Coptis Chinensis Franch. -containing traditional Chinese medicine as an adjunct therapy to metformin in the treatment of type 2 diabetes mellitus
por: Pan, Linlin, et al.
Publicado: (2023) -
Cytokine storm-calming property of the isoquinoline alkaloids in Coptis chinensis Franch
por: Lan, Yuejia, et al.
Publicado: (2022) -
UPLC-QTOF/MS Analysis of Alkaloids in Traditional Processed Coptis chinensis Franch.
por: Jiang, Xue, et al.
Publicado: (2012) -
Neuroprotective Activity of Coptisine from Coptis chinensis (Franch)
por: Friedemann, Thomas, et al.
Publicado: (2015) -
Dissecting and Evaluating the Therapeutic Targets of Coptis Chinensis Franch in the Treatment of Urinary Tract Infections Induced by Escherichia coli
por: Chang, Zhenglin, et al.
Publicado: (2022)